483
Johnson & Johnson Consumer, IncJohnson & Johnson Consumer, Inc – FDA 483, Mar 24, 2021
Record Details
Johnson & Johnson Consumer, Inc. in Lancaster, PA, a drug manufacturer, was cited for failing to thoroughly review batch failures and their components. Specifically, the firm's investigation reports for Imodium Multi-Symptom Relief tablet compression and yield deviations were inadequate in assessing root causes and implementing effective corrective and preventative actions. This indicates a significant lapse in quality control and investigation processes.
View Company Profile
ID · 451e3a89-7423-4e12-b139-81b82b0bf727
Other documents for Johnson & Johnson Consumer, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.